Meeting
2022 ASCO Annual Meeting
Analysis of genomic alterations in pan-cancer from a large real-world Chinese population.
Authors
Zhouhuan Dong
Department of Pathology, The Chinese PLA General Hospital, Beijing, China
Zhouhuan Dong , Jie Gao , Fengwei Zhu , Fei Gai , Wenqing Su , Zhixin Liang , Xiaodong Tian , Huaiyin Shi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Etiology/Epidemiology
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 10568)
DOI
10.1200/JCO.2022.40.16_suppl.10568
Abstract #
10568
Poster Bd #
444
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Impact of rapid multigene assays with short turnaround time (TAT) on the development of precision medicine for non-small cell lung cancer (NSCLC).
First Author: Shingo Matsumoto
Poster
2014 ASCO Annual Meeting
Next-generation sequencing (NGS) to identify actionable genomic alterations (GA) in “pan-negative” lung adenocarcinomas (ADC) from patients with no smoking or a light smoking (NS/LS) history.
First Author: Alexander E. Drilon
Poster
2012 ASCO Annual Meeting
Use of next-generation sequencing (NGS) to detect a novel ALK fusion and a high frequency of other actionable alterations in colorectal cancer (CRC).
First Author: Jeffrey S. Ross
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Incidence and genomic characteristics of gene fusions in a large Chinese colorectal cancer cohort.
First Author: Furong Kou